Home
Contact
Publications
Development of a versatile oncolytic virus platform for local intra-tumoural expression of therapeutic transgenes
18th May 2017
adm1n
T-SIGn
Click here for Full Text
Share this Story
Facebook
Twitter
LinkedIn
Reddit
Digg
Delicious
Google++
E-Mail+
About the Author
Comments are closed.
Prev Post
Next Post
Filter Publications
Enadenotucirev Preclinical
Enadenotucirev Clinical
T-SIGn
Reviews
See All Publications
© Copyright 2022 PsiOxus Therapeutics
RSS
Back to Top
About
Vision & Strategy
Our People
T-SIGn Platform Technology
Pipeline
Publications and Posters
Partners and Investors
News and Events
Careers
Contact Us
Menu
Comments are closed.